To prevent AAD in children, tht recommends the probiotic formula Prolactys® Kids AAD Prevention
- L. rhamnosus
- B. animalis lactis
- S. thermophillus
- S. boulardii
Prolactys® kids AAD Prevention
STAY IN CONTROL OF YOUR GUT.
Antibiotic-associated diarrhea is a common complication of antibiotic therapy, defined as diarrhea that occurs in relation to antibiotic treatment.
AAD results from disruption of the normal microflora of the gut by antibiotics. If the use of probiotics for preventing AAD is considered, the ESPGHAN WG recommends using L. rhamnosus GG or S. boulardii.
A study done in USA reported that 11% of children on various antibiotics developed AAD and mild illness.
More than two third during the therapy and 15% in the week following stopping antibiotic (Journal of Pediatric Gastroenterology and Nutrition, 01 Jul 2003, 37(1):22-26).
What are probiotics in the prolactys kids AAD Prevention range of tht ?
The most recent definition of probiotics has been established by the International Scientific Association for Probiotics and Prebiotics (ISAPP).
Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host
The probiotic market for kids is witnessing substantial growth in regions such as North America, Asia Pacific, and Europe. From 2024 to 2034, the market is growing with a CAGR of 5.30% due to the growing number of incidents in kids with digestive disorders (FMI Future Market Insight. April 2024).
References
- Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R, et al. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 2014;58:531-9.
- Szajewska H, Skórka A, Ruszczyński M, Gieruszczak-Białek D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children–updated analysis of randomised controlled trials. Aliment Pharmacol Ther 2013;38:467-76
- Naflesia B. O. Correa, MD, Luciano A. Peret Filho, MD, PhD, Francisco J. Penna, MD, PhD, Fatima M. L. S. Lima, MD and Jacques R. Nicoli, PhD.; A Randomized Formula Controlled Trial of Bifidobacterium lactis and Streptococcus thermophilus for Prevention of Antibiotic-Associated Diarrhea in Infants; 2005.
We are here to support you
More information?
More about our main strains
For any additional information on our strain, you can use the form below. Our experts will be happy to provide you with all the necessary information.
Contact us
Disclaimer: tht has provided the information here in good faith and based on the best of its current knowledge of the situation. It does not constitute a regulatory advice and it is not a substitute for customers conducting their own legal/regulatory assessments to make their own decisions. You are encouraged to confirm this information with legal/regulatory advice from professionals familiar with your factual situation. tht does not accept any liability by reliance on this information.
